GM1 Oligosaccharide Ameliorates Rett Syndrome Phenotypes In Vitro and In Vivo via Trk Receptor Activation.

MLA

Fazzari, Maria, et al. “GM1 Oligosaccharide Ameliorates Rett Syndrome Phenotypes In Vitro and In Vivo via Trk Receptor Activation.” International Journal of Molecular Sciences, vol. 25, no. 21, Oct. 2024. EBSCOhost, https://doi.org/10.3390/ijms252111555.

APA

Fazzari, M., Lunghi, G., Carsana, E. V., Valsecchi, M., Spiombi, E., Breccia, M., Casati, S. R., Pedretti, S., Mitro, N., Mauri, L., Ciampa, M. G., Sonnino, S., Landsberger, N., Frasca, A., & Chiricozzi, E. (2024). GM1 Oligosaccharide Ameliorates Rett Syndrome Phenotypes In Vitro and In Vivo via Trk Receptor Activation. International Journal of Molecular Sciences, 25(21). https://doi.org/10.3390/ijms252111555

Chicago

Fazzari, Maria, Giulia Lunghi, Emma Veronica Carsana, Manuela Valsecchi, Eleonora Spiombi, Martina Breccia, Silvia Rosanna Casati, et al. 2024. “GM1 Oligosaccharide Ameliorates Rett Syndrome Phenotypes In Vitro and In Vivo via Trk Receptor Activation.” International Journal of Molecular Sciences 25 (21). doi:10.3390/ijms252111555.